Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer
Choose from the criteria below to find an activity that fits you best.
Note: If you attended the live CE activity AND received CE credit (i.e. a pharmacist or pharmacy technician CE statement of credit with ACPE UAN 0221-9999-21-270-L04-P/T), you are NOT allowed to also receive credit for this home-study on-demand web activity.
In this 2-part CE webinar series, pharmacists and pharmacy technicians will learn
about the design and findings of four research studies that evaluated how fully-integrated
health system specialty pharmacy services impact patient care and clinical outcomes.
Presenters will also share practical recommendations for designing and implementing a successful research study and answer attendees’ questions about their research studies.
Part 2 of this CE webinar series includes the following research studies and faculty:
The target audience for this activity includes pharmacists and pharmacy technicians.
Pharmacist Learning Objectives
After attending this webinar, pharmacists will be able to:
Pharmacy Technician Learning Objectives
After attending this webinar, pharmacy technicians will be able to:
Brandon Newman, PharmD, CSP, MMHC, Vice President of Clinical Affairs at Trellis Rx
Release Date: November 3, 2021
Expiration Date: November 3, 2022
This activity is jointly provided by ProCE, LLC and Trellis Rx. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-270-H04-P/T has been assigned to this home study knowledge-based activity. This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Brandon Hardin has disclosed receiving fees for non-CME/CE services from Amgen Inc., and consulting fees from Impel NeuroPharma Inc. All of the other faculty presenters (moderator and panelists) have no relevant conflicts of interest to report.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.